Alector (ALEC) Net Cash Flow (2018 - 2026)
Alector (ALEC) posted quarterly Net Cash Flow of $11.2 million for Q1 2026, up 125.36% year-over-year from $5.0 million in Q1 2025, and up 204.29% quarter-over-quarter from -$10.7 million in Q4 2025.
Alector (ALEC) Net Cash Flow (2018 - 2026) Analysis & Trends
Alector (ALEC) has reported Net Cash Flow for 9 consecutive years, with $11.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Net Cash Flow rose 125.36% year-over-year to $11.2 million; the TTM figure through Mar 2026 stood at $39.0 million (up 213.74% YoY), while the FY2025 annual figure was $32.8 million, up 179.5% from the prior year.
- Net Cash Flow advanced to $11.2 million in Q1 2026 per ALEC's latest filing, from -$10.7 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $125.5 million in Q1 2022 and bottomed at -$282.4 million in Q2 2022.
- Historically, Net Cash Flow has averaged -$14.8 million across 5 years, with a median of -$3.8 million in 2024.
- Annual changes were most pronounced in 2022 — Net Cash Flow sank 1981.11% — and 2025, when it surged 405.53%.
- Alector's Net Cash Flow stood at -$29.9 million in 2022, then grew by 8.36% to -$27.4 million in 2023, then jumped by 86.0% to -$3.8 million in 2024, then slumped by 178.82% to -$10.7 million in 2025, then soared by 204.29% to $11.2 million in 2026.
- Business Quant data shows ALEC's Net Cash Flow at $11.2 million in Q1 2026, -$10.7 million in Q4 2025, and $31.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 652.90 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.30 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 407.41 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 17.81 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -496,000.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.14 Mn |
| 10 | Alector | 218.85 Mn | 46.05 Mn | - | -17.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -17.05 Mn |
| Jun 30, 2026 | -17.05 Mn |
| Mar 31, 2026 | 11.16 Mn |
| Mar 31, 2026 | 11.16 Mn |
| Dec 31, 2025 | -10.70 Mn |
| Dec 31, 2025 | -10.70 Mn |
| Sep 30, 2025 | 31.73 Mn |
| Sep 30, 2025 | 31.73 Mn |
| Jun 30, 2025 | 6.80 Mn |
| Jun 30, 2025 | 6.80 Mn |
| Mar 31, 2025 | 4.95 Mn |
| Mar 31, 2025 | 4.95 Mn |
| Dec 31, 2024 | -3.84 Mn |
| Dec 31, 2024 | -3.84 Mn |
| Sep 30, 2024 | -10.39 Mn |
| Sep 30, 2024 | -10.39 Mn |
| Jun 30, 2024 | -25.01 Mn |
| Jun 30, 2024 | -25.01 Mn |
| Mar 31, 2024 | -2.00 Mn |
| Mar 31, 2024 | -2.00 Mn |